wrong, others have posted refutes of this today with direct quotes from the FDA, downramper shorter be gone... with these key secondaries being so significant they can get conditional approval with further trial post approval
- Forums
- ASX - By Stock
- MSB
- Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
MSB
mesoblast limited
Add to My Watchlist
4.15%
!
$2.31

Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-425
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.31 |
Change
-0.100(4.15%) |
Mkt cap ! $2.956B |
Open | High | Low | Value | Volume |
$2.33 | $2.35 | $2.15 | $30.94M | 13.57M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 75954 | $2.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 10350 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 75954 | 2.300 |
1 | 8580 | 2.290 |
2 | 10438 | 2.280 |
7 | 19928 | 2.270 |
3 | 9726 | 2.260 |
Price($) | Vol. | No. |
---|---|---|
2.320 | 10350 | 2 |
2.340 | 56503 | 6 |
2.350 | 108804 | 14 |
2.360 | 31450 | 3 |
2.380 | 18175 | 4 |
Last trade - 16.17pm 21/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |